4imprint Group (FOUR) shares ticked up 7.20% to 2,682.5p following significant recovery
In a trading update published on Friday, 4imprint said revenue had significantly increased and that it expects profit to be at the upper end of forecasts after a strong recovery over the year.
It reported revenue for the year to 1 January 202 at around $787m, a 41% rise on 2020. Meanwhile, pre-tax profit is expected to be towards the upper end of analysts’ forecasts.
Total order count in 2021 was 90% of the 2019 comparative (the most recent ‘normal’ year), which it said demonstrated a strong recovery in the business over the course of the year.
In addition, the company reported unaudited net cash balance at the 2021 year-end at $41.6m, (2020: $39.8m), which it said leaves it in a good financial position entering 2022.
Sensyne Health (SENS) shares jump 21.31% to 18.5p as it completes financing round
Today, the UK clinical AI company announced that it has now completed a financing which comprises up to £11.35m which will fund Sensyne through an ongoing formal sale process.
The company said it has received a £6.35m first tranche of an agreed £11.35m facility. Meanwhile, CEO, Lord Drayson has proposed to reduce his base salary to £1 per year.
Addressing shareholders, Sensyne Health said Lord Drayson has confirmed his commitment to the company’s mission and “its unique ethical business model” for the use of anonymised patient data in medical research in partnership with the NHS and health systems world-wide.
Hargreaves Services (HSP) shares tick up 17.63% to 478p as it forecasts further momentum
In its results for the six months to 30 November 2021, Hargreaves Services said it expects to carry momentum into the second half of the financial year in all segments of the business.
Commenting on the interim results this morning, Chairman, Roger McDowell, said Hargreaves Services had delivered “a strong set of results” as profits increased in all business segments.
He said 1H had been “a period of demonstrable momentum” in each of the three businesses.
Whilst revenue reduced to £76.1m from £92m in 2020 as expected, the group’s pre-tax profit increased substantially to £10.4m (2020: £1.1m). The Group also held net cash of £8.5m on 30 November 2021, compared to a net bank debt position of £8.0m twelve months ago.
Its performance has enabled the Board to increase the interim dividend by 3.7% to 2.8p.
Revolution Beauty (REVB) shares rise 17.2% to 113.25p as outlook remains unchanged
Revolution said the Christmas trading period from 1 November through to 31 December 2021 was strong and in line with expectations with group revenues increasing by 41% year-on-year.
In a trading update, the UK-based beauty company hailed its performance over the period despite the volatile consumer backdrop which saw many of its markets going into lockdown.
Looking ahead,the group said The Masterbrand of Makeup Revolution commences its launch into Boots stores on 21 February 2022 rolling out into the top 336 Boots stores across the UK.
It said this will see Revolution Beauty sell its products across four categories - Cosmetics, Skincare, Haircare and Gifting - within the UK’s leading Health and Beauty Retailer.
Whilst it remains mindful of the volatile external environment and the phasing of distribution expansions in January and February, the group’s guidance for the year remains unchanged.